Compare RDY & DRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDY | DRS |
|---|---|---|
| Founded | 1984 | 1969 |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6B | 9.7B |
| IPO Year | N/A | N/A |
| Metric | RDY | DRS |
|---|---|---|
| Price | $14.19 | $33.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $16.90 | ★ $46.83 |
| AVG Volume (30 Days) | 938.9K | ★ 966.0K |
| Earning Date | 01-22-2026 | 10-29-2025 |
| Dividend Yield | 0.50% | ★ 1.06% |
| EPS Growth | 9.95 | ★ 33.93 |
| EPS | 0.79 | ★ 0.99 |
| Revenue | ★ $3,851,623,984.00 | $3,569,000,000.00 |
| Revenue This Year | $6.16 | $11.94 |
| Revenue Next Year | $2.57 | $6.66 |
| P/E Ratio | ★ $17.87 | $34.27 |
| Revenue Growth | ★ 14.10 | 12.27 |
| 52 Week Low | $12.26 | $28.17 |
| 52 Week High | $16.17 | $49.31 |
| Indicator | RDY | DRS |
|---|---|---|
| Relative Strength Index (RSI) | 57.67 | 38.52 |
| Support Level | $13.64 | $32.84 |
| Resistance Level | $14.20 | $34.86 |
| Average True Range (ATR) | 0.16 | 0.84 |
| MACD | 0.05 | 0.29 |
| Stochastic Oscillator | 98.25 | 41.09 |
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
Leonardo DRS Inc is a provider of defense products and technologies that are used across land, air, sea, space, and cyber domains. The company is in the design, development, and manufacture of Advanced sensing, network computing, force protection, and electric power and propulsion technologies and solutions. The company has two segments: Advanced Sensing and Computing, which generates the majority of revenue, and the Integrated Mission Systems segment. The Advanced Sensing and Computing segment is engaged in designing, developing, and manufacturing sensing and network computing technology that enables real-time situational awareness required for enhanced operational decision-making and execution by the customers.